Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Hypnotics Stories

2011-07-07 05:30:00

ANAHEIM, Calif., July 7, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release second quarter 2011 financial results on Tuesday, July 26, 2011 after the close of the U.S. financial markets. The Company will host a conference call and webcast on Tuesday, July 26, 2011 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the second quarter, as well as current corporate developments. Conference call details:...

2011-06-24 05:10:00

EXTON, Pa., June 24, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a Pediatric Use Marketing Authorization (PUMA) for Buccolam® (midazolam, oromucosal solution), for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less...

2011-06-22 12:07:00

BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I pharmacokinetic study. The propriety formulation was designed and manufactured at Particle Sciences. In the Phase 1 clinical trial NRL-1 demonstrated a pharmacokinetic profile comparable to that reported in the literature for Diastat® (rectal diazepam gel), the only FDA approved...

2011-06-17 13:08:00

JERSEY CITY, N.J., June 17, 2011 /PRNewswire/ -- Aoxing Pharmaceutical (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has been granted a patent by the State Intellectual Property Office of The People's Republic of China for midazolam maleate oral film. The Chinese...

2011-06-15 06:23:18

(Ivanhoe Newswire)--For people who suffer from insomnia, the metabolism in the brain's frontal cortex increases, making it difficult to fall asleep. According to a recent study, people with primary insomnia may be able to find relief by wearing a cap that cools the brain at night. One way to reduce cerebral metabolic activity is to use a process called "cerebral hypothermia," in which the frontal cerebral thermal transfers to cool the brain. But can this non-pharmaceutical method really cure...

2011-06-14 12:37:00

SAN DIEGO, June 14, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the results of a randomized crossover study in healthy volunteers assessing diazepam pharmacokinetics and bioavailability after administration of their proprietary intranasal diazepam formulations and intravenous injection. The study was designed and conducted in collaboration with investigators at the University of Minnesota. Comparative analysis of the lead intranasal formulation, NRL-1, revealed promising...

2011-06-13 14:43:34

Study finds that treatment with frontal cerebral thermal transfer can eliminate insomnia symptoms People with primary insomnia may be able to find relief by wearing a cap that cools the brain during sleep, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS). According to the authors, a reduction in metabolism in the brain's frontal cortex occurs while...

2011-06-06 16:00:00

MORRISTOWN, N.J., June 6, 2011 /PRNewswire/ -- Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced. Actavis was the first company to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength in October 2010 with 180-day exclusivity. Zolpidem Tartrate...

2011-04-22 00:00:30

The Effortless Sleep Method, a book detailing a new, natural insomnia treatment method is now available at Amazon. (PRWEB) April 21, 2011 The Effortless Sleep Method, a book detailing a new, natural insomnia treatment method is now available at Amazon. Sasha Stephens, Sleep Therapist, author of Effortless-Sleep.com and the Effortless Sleep Method book is excited to have her insomnia treatment method available through Amazon. Sasha Stephens comments, "The Effortless Sleep Method has helped...

2011-04-20 08:00:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection. Through the collaboration with the University of Minnesota and James Cloyd, PharmD; Neurelis has partnered with the leading experts in clinical research of the nasal delivery of benzodiazepines....